Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Rhodium Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN1160350C details a rhodium-catalyzed route for high-purity chiral lactones, offering significant cost reduction in API manufacturing and reliable supply chain continuity.
Patent CN114605302B analysis reveals efficient rhodium catalysis for axial chirality. Offers supply chain reliability and cost reduction in pharmaceutical intermediates manufacturing.
Patent CN106632086B details a Rhodium-catalyzed C-H iodination method for quinazolines. This process offers high purity, mild conditions, and significant cost reduction in pharmaceutical intermediate manufacturing.
Discover the Rh-catalyzed asymmetric hydrogenation patent CN116444412A for chiral trifluoromethyl nitrogen heterocycles. Achieve high ee values and cost reduction in pharmaceutical intermediate manufacturing with scalable solutions.
Patent CN101175715B details Rh-catalyzed hydrogenation using PhanePhos for high-purity 3,3-diarylalanine intermediates, offering scalable API synthesis solutions.
Discover the advanced Rh-catalyzed C-H olefination method for synthesizing pyrrole ethylene derivatives. A reliable solution for high-purity pharmaceutical intermediates manufacturing.
Patent CN112824421A reveals a robust chiral ligand synthesis route offering high enantioselectivity and TON up to 10000 for pharmaceutical manufacturing.
Patent CN114716356B reveals green rhodium catalysis for isothiocyanates. Offers high purity, mild conditions, and supply chain stability for pharma intermediates.
Novel synthesis of chiral optical pure alkynylamide substituted α,β-diamino acid derivatives via Rh-catalyzed three-component reaction for potent anticancer applications.
Patent CN109678911B details a high-efficiency Rh-catalyzed method for planar chiral ferrocene intermediates, offering superior enantioselectivity and supply chain reliability.
Novel Rh-catalyzed C-H activation method for high-purity axial chiral intermediates with superior enantioselectivity and scalable process efficiency.
Patent CN114773301A details a mild Rh(III) catalyzed route to furans. This technology offers significant cost reduction in API manufacturing through efficient cyclization.
Novel one-pot Rh(III) catalysis for nitrogen heterocycles. High yield, mild conditions, cost-effective supply chain solution.
Patent CN108395412A reveals a novel Rh-catalyzed synthesis for triazole derivatives, offering streamlined production and cost advantages for pharmaceutical and agrochemical supply chains.
Patent CN111285846B details a novel Rh-catalyzed C-H activation route for 2-(2-indolyl)-acetates, offering cost reduction and scalable manufacturing for pharma intermediates.
Novel Rh-catalyzed asymmetric hydrogenation avoids resolution, boosting yield to 42.55% for reliable API intermediate supply.
Patent CN111196791B reveals a novel Rh-catalyzed route to chiral gamma-butyrolactones with high enantioselectivity, offering cost-effective API intermediate solutions.
Patent CN107868087A details a rhodium-catalyzed method for pyrroloindole derivatives, offering cost reduction in pharmaceutical intermediates manufacturing and enhanced supply chain reliability.
Novel Rh-catalyzed method for trifluoromethyl enaminones. Reduces cost and improves scalability for pharmaceutical manufacturing.
Novel Rh-catalyzed C-H activation for trifluoromethyl enaminones. High purity pharmaceutical intermediates with scalable cost reduction.